Header Logo

Connection

David Smelson to Female

Back to Details
This is a "connection" page, showing publications David Smelson has written about Female.
David Smelson
Connection Strength
1.004
Female
  1. Bruzios K, Shaffer PM, Blonigen DM, Cucciare MA, Andre M, Byrne T, Smith J, Smelson D. Intervention for Justice-Involved Homeless Veterans With Co-Occurring Substance Use and Mental Health Disorders: Protocol for a Randomized Controlled Hybrid Effectiveness-Implementation Trial. JMIR Res Protoc. 2025 Jul 18; 14:e70750.
    View in: PubMed
    Score: 0.052
  2. Helm A, Shaffer P, Gonzalez G, Li W, Olmstead T, Berlowitz D, Epstein E, Smelson D. Protocol of a randomized controlled trial examining psychosocial enhancement and standard medication treatment for co-occurring opioid use and mental health disorders: A half fractional factorial randomized controlled trial. Contemp Clin Trials. 2024 Oct; 145:107668.
    View in: PubMed
    Score: 0.049
  3. Helm AF, Andre MA, Shaffer PM, Bruzios KE, Marcus S, Harter J, Smelson D. Multicomponent Co-Occurring Disorders Treatment and Wraparound Services for Individuals Experiencing Chronic Homelessness. Community Ment Health J. 2024 Aug; 60(6):1203-1213.
    View in: PubMed
    Score: 0.048
  4. Blonigen DM, Macia KS, Cucciare MA, Smelson D. For whom are treatments for criminal recidivism effective? Moderator effects from a randomized controlled trial of justice-involved veterans. J Consult Clin Psychol. 2024 Feb; 92(2):118-128.
    View in: PubMed
    Score: 0.047
  5. Blonigen DM, Shaffer PM, Baldwin N, Smelson D. Disentangling the relationship between posttraumatic stress disorder, criminogenic risk, and criminal history among veterans. Law Hum Behav. 2023 10; 47(5):579-590.
    View in: PubMed
    Score: 0.046
  6. Gaba A, Helm A, Shaffer PM, Pridgen B, Drawbridge D, Smelson D. Community reentry: Racial/ethnic differences in unmet needs among adults with co-occurring opioid use and mental health disorder. Int J Law Psychiatry. 2023 Nov-Dec; 91:101924.
    View in: PubMed
    Score: 0.046
  7. Blonigen DM, Cucciare MA, Byrne T, Shaffer PM, Giordano B, Smith JS, Timko C, Rosenthal J, Smelson D. A randomized controlled trial of moral reconation therapy to reduce risk for criminal recidivism among justice-involved adults in mental health residential treatment. J Consult Clin Psychol. 2022 May; 90(5):413-426.
    View in: PubMed
    Score: 0.042
  8. Pinals DA, Gaba A, Clary KM, Barber J, Reiss J, Smelson D. Implementation of MISSION-Criminal Justice in a Treatment Court: Preliminary Outcomes Among Individuals With Co-occurring Disorders. Psychiatr Serv. 2019 11 01; 70(11):1044-1048.
    View in: PubMed
    Score: 0.034
  9. Corrigan PW, Qin S, Davidson L, Schomerus G, Shuman V, Smelson D. Public Perceptions of Recovery Prospects and Peer Style (Support and Confrontation) in Services for Serious Mental Illness Versus Substance Use Disorder. J Dual Diagn. 2019 Oct-Dec; 15(4):226-232.
    View in: PubMed
    Score: 0.034
  10. Corrigan PW, Qin S, Davidson L, Schomerus G, Shuman V, Smelson D. How does the public understand recovery from severe mental illness versus substance use disorder? Psychiatr Rehabil J. 2019 Dec; 42(4):341-349.
    View in: PubMed
    Score: 0.034
  11. Smelson DA, Perez CK, Farquhar I, Byrne T, Colegrove A. Permanent Supportive Housing and Specialized Co-Occurring Disorders Wraparound Services for Homeless Individuals. J Dual Diagn. 2018 Oct-Dec; 14(4):247-256.
    View in: PubMed
    Score: 0.033
  12. Jasuja GK, Ameli O, Miller DR, Land T, Bernson D, Rose AJ, Berlowitz DR, Smelson DA. Overdose risk for veterans receiving opioids from multiple sources. Am J Manag Care. 2018 11; 24(11):536-540.
    View in: PubMed
    Score: 0.033
  13. Smelson DA, Chinman M, Hannah G, Byrne T, McCarthy S. An evidence-based co-occurring disorder intervention in VA homeless programs: outcomes from a hybrid III trial. BMC Health Serv Res. 2018 May 05; 18(1):332.
    View in: PubMed
    Score: 0.032
  14. Smelson D, Farquhar I, Fisher W, Pressman K, Pinals DA, Samek B, Duffy MK, Sawh L. Integrating a Co-occurring Disorders Intervention in Drug Courts: An Open Pilot Trial. Community Ment Health J. 2019 02; 55(2):222-231.
    View in: PubMed
    Score: 0.031
  15. Trojano ML, Christopher PP, Pinals DA, Harnish A, Smelson D. Perceptions of voluntary consent among jail diverted veterans with co-occurring disorders. Behav Sci Law. 2017 Sep; 35(5-6):408-417.
    View in: PubMed
    Score: 0.030
  16. Harnish A, Corrigan P, Byrne T, Pinals DA, Rodrigues S, Smelson D. Substance Use and Mental Health Stigma in Veterans With Co-Occurring Disorders. J Dual Diagn. 2016 Jul-Dec; 12(3-4):238-243.
    View in: PubMed
    Score: 0.028
  17. Smelson DA, Zaykowski H, Guevermont N, Siegfriedt J, Sawh L, Modzelewski D, Tsemberis S, Kane V. Integrating Permanent Supportive Housing and Co-Occurring Disorders Treatment for Individuals Who Are Homeless. J Dual Diagn. 2016 Apr-Jun; 12(2):193-201.
    View in: PubMed
    Score: 0.027
  18. Smelson DA, Kline A, Kuhn J, Rodrigues S, O'Connor K, Fisher W, Sawh L, Kane V. A wraparound treatment engagement intervention for homeless veterans with co-occurring disorders. Psychol Serv. 2013 May; 10(2):161-7.
    View in: PubMed
    Score: 0.022
  19. Smelson D, Chen KW, Ziedonis D, Andes K, Lennox A, Callahan L, Rodrigues S, Eisenberg D. A pilot study of Qigong for reducing cocaine craving early in recovery. J Altern Complement Med. 2013 Feb; 19(2):97-101.
    View in: PubMed
    Score: 0.021
  20. Smelson D, Kalman D, Losonczy MF, Kline A, Sambamoorthi U, Hill LS, Castles-Fonseca K, Ziedonis D. A brief treatment engagement intervention for individuals with co-occurring mental illness and substance use disorders: results of a randomized clinical trial. Community Ment Health J. 2012 Apr; 48(2):127-32.
    View in: PubMed
    Score: 0.019
  21. Pivovarova E, Taxman FS, Boland AK, Andraka-Christou B, De La Cruz BA, Smelson D, Lemon SC, Friedmann PD. Medication for Opioid Use Disorders (MOUD) Providers' Experiences with Recovery Courts: Qualitative Study of Individual and Systemic Factors Impacting Interagency Collaboration. Subst Use Addctn J. 2025 Jul; 46(3):531-540.
    View in: PubMed
    Score: 0.013
  22. Carreiro S, Ramanand P, Akram W, Stapp J, Chapman B, Smelson D, Indic P. Developing a Wearable Sensor-Based Digital Biomarker of Opioid Dependence. Anesth Analg. 2025 Aug 01; 141(2):393-402.
    View in: PubMed
    Score: 0.012
  23. Bowdring MA, Macia KS, Shaffer PM, Smelson D, Blonigen DM. Criminogenic Needs and?Legal Problem Severity Among Legal System Involved Veterans. Mil Med. 2024 Jul 03; 189(7-8):e1544-e1551.
    View in: PubMed
    Score: 0.012
  24. Carreiro S, Ramanand P, Taylor M, Leach R, Stapp J, Sherestha S, Smelson D, Indic P. Evaluation of a digital tool for detecting stress and craving in SUD recovery: An observational trial of accuracy and engagement. Drug Alcohol Depend. 2024 Aug 01; 261:111353.
    View in: PubMed
    Score: 0.012
  25. Smelson DA, Losonczy MF, Davis CW, Kaune M, Williams J, Ziedonis D. Risperidone decreases craving and relapses in individuals with schizophrenia and cocaine dependence. Can J Psychiatry. 2002 Sep; 47(7):671-5.
    View in: PubMed
    Score: 0.011
  26. Smelson DA, Roy A, Roy M, Tershakovec D, Engelhart C, Losonczy MF. Electroretinogram and cue-elicited craving in withdrawn cocaine-dependent patients: a replication. Am J Drug Alcohol Abuse. 2001 May; 27(2):391-7.
    View in: PubMed
    Score: 0.010
  27. Holzhauer CG, Epstein EE, Smelson DA, Mattocks K. Targeting women veteran's stress-induced drinking with cognitive reappraisal: Mechanisms and moderators of change. J Subst Abuse Treat. 2021 11; 130:108408.
    View in: PubMed
    Score: 0.010
  28. Finlay AK, Harris AHS, Timko C, Yu M, Smelson D, Stimmel M, Binswanger IA. Disparities in Access to Medications for Opioid Use Disorder in the Veterans Health Administration. J Addict Med. 2021 04 01; 15(2):143-149.
    View in: PubMed
    Score: 0.010
  29. Jasuja GK, Bettano A, Smelson D, Bernson D, Rose AJ, Byrne T, Berlowitz DR, McCullough MB, Miller DR. Homelessness and Veteran Status in Relation to Nonfatal and Fatal Opioid Overdose in Massachusetts. Med Care. 2021 04 01; 59(Suppl 2):S165-S169.
    View in: PubMed
    Score: 0.010
  30. Morse E, Binswanger IA, Taylor E, Gray C, Stimmel M, Timko C, Harris AHS, Smelson D, Finlay AK. Strategies to improve implementation of medications for opioid use disorder reported by veterans involved in the legal system: A qualitative study. J Subst Abuse Treat. 2021 10; 129:108353.
    View in: PubMed
    Score: 0.010
  31. Byrne T, Baggett T, Land T, Bernson D, Hood ME, Kennedy-Perez C, Monterrey R, Smelson D, Dones M, Bharel M. A classification model of homelessness using integrated administrative data: Implications for targeting interventions to improve the housing status, health and well-being of a highly vulnerable population. PLoS One. 2020; 15(8):e0237905.
    View in: PubMed
    Score: 0.009
  32. Ellison ML, Schutt RK, Yuan LH, Mitchell-Miland C, Glickman ME, McCarthy S, Smelson D, Schultz MR, Chinman M. Impact of Peer Specialist Services on Residential Stability and Behavioral Health Status Among Formerly Homeless Veterans With Cooccurring Mental Health and Substance Use Conditions. Med Care. 2020 04; 58(4):307-313.
    View in: PubMed
    Score: 0.009
  33. Carreiro S, Chintha KK, Shrestha S, Chapman B, Smelson D, Indic P. Wearable sensor-based detection of stress and craving in patients during treatment for substance use disorder: A mixed methods pilot study. Drug Alcohol Depend. 2020 04 01; 209:107929.
    View in: PubMed
    Score: 0.009
  34. Midboe AM, Byrne T, Smelson D, Jasuja G, McInnes K, Troszak LK. The Opioid Epidemic In Veterans Who Were Homeless Or Unstably Housed. Health Aff (Millwood). 2019 08; 38(8):1289-1297.
    View in: PubMed
    Score: 0.009
  35. Holzhauer CG, Byrne T, Simmons MM, Smelson D, Epstein EE. Profiles of Clinical Need Among Homeless Individuals with Dual Diagnoses. Community Ment Health J. 2019 11; 55(8):1305-1312.
    View in: PubMed
    Score: 0.009
  36. Smelson DA, McGee-Caulfield E, Bergstein P, Engelhart C. Initial validation of the Voris Cocaine Craving Scale: a preliminary report. J Clin Psychol. 1999 Jan; 55(1):135-9.
    View in: PubMed
    Score: 0.008
  37. Rogers ES, Gillespie C, Smelson D, Sherman SE. A Qualitative Evaluation of Mental Health Clinic Staff Perceptions of Barriers and Facilitators to Treating Tobacco Use. Nicotine Tob Res. 2018 09 04; 20(10):1223-1230.
    View in: PubMed
    Score: 0.008
  38. Smelson DA, Roy M, Roy A, Santana S. Electroretinogram in withdrawn cocaine-dependent subjects. Relationship to cue-elicited craving. Br J Psychiatry. 1998 Jun; 172:537-9.
    View in: PubMed
    Score: 0.008
  39. Simmons MM, Fincke BG, Drainoni ML, Kim B, Byrne T, Smelson D, Casey K, Ellison ML, Visher C, Blue-Howells J, McInnes DK. A two-state comparative implementation of peer-support intervention to link veterans to health-related services after incarceration: a study protocol. BMC Health Serv Res. 2017 Sep 12; 17(1):647.
    View in: PubMed
    Score: 0.008
  40. Desai P, Roy M, Roy A, Brown S, Smelson D. Impaired color vision in cocaine-withdrawn patients. Arch Gen Psychiatry. 1997 Aug; 54(8):696-9.
    View in: PubMed
    Score: 0.008
  41. Blonigen DM, Rodriguez AL, Manfredi L, Nevedal A, Rosenthal J, McGuire JF, Smelson D, Timko C. Cognitive-behavioral treatments for criminogenic thinking: Barriers and facilitators to implementation within the Veterans Health Administration. Psychol Serv. 2018 Feb; 15(1):87-97.
    View in: PubMed
    Score: 0.007
  42. Krebs P, Rogers E, Smelson D, Fu S, Wang B, Sherman S. Relationship between tobacco cessation and mental health outcomes in a tobacco cessation trial. J Health Psychol. 2018 07; 23(8):1119-1128.
    View in: PubMed
    Score: 0.007
  43. Okunna NC, Rodriguez-Monguio R, Smelson DA, Poudel KC, Volberg R. Gambling involvement indicative of underlying behavioral and mental health disorders. Am J Addict. 2016 Mar; 25(2):160-72.
    View in: PubMed
    Score: 0.007
  44. Finlay AK, Harris AH, Rosenthal J, Blue-Howells J, Clark S, McGuire J, Timko C, Frayne SM, Smelson D, Oliva E, Binswanger I. Receipt of pharmacotherapy for opioid use disorder by justice-involved U.S. Veterans Health Administration patients. Drug Alcohol Depend. 2016 Mar 01; 160:222-6.
    View in: PubMed
    Score: 0.007
  45. Rogers ES, Smelson DA, Gillespie CC, Elbel B, Poole S, Hagedorn HJ, Kalman D, Krebs P, Fang Y, Wang B, Sherman SE. Telephone Smoking-Cessation Counseling for Smokers in Mental Health Clinics: A Patient-Randomized Controlled Trial. Am J Prev Med. 2016 Apr; 50(4):518-527.
    View in: PubMed
    Score: 0.007
  46. Carreiro S, Fang H, Zhang J, Wittbold K, Weng S, Mullins R, Smelson D, Boyer EW. iMStrong: Deployment of a Biosensor System to Detect Cocaine Use. J Med Syst. 2015 Dec; 39(12):186.
    View in: PubMed
    Score: 0.007
  47. Gonzalez G, DiGirolamo G, Romero-Gonzalez M, Smelson D, Ziedonis D, Kolodziej M. Memantine improves buprenorphine/naloxone treatment for opioid dependent young adults. Drug Alcohol Depend. 2015 Nov 01; 156:243-253.
    View in: PubMed
    Score: 0.007
  48. Finlay AK, Binswanger IA, Smelson D, Sawh L, McGuire J, Rosenthal J, Blue-Howells J, Timko C, Blodgett JC, Harris AH, Asch SM, Frayne S. Sex differences in mental health and substance use disorders and treatment entry among justice-involved Veterans in the Veterans Health Administration. Med Care. 2015 Apr; 53(4 Suppl 1):S105-11.
    View in: PubMed
    Score: 0.006
  49. DiGirolamo GJ, Smelson D, Guevremont N. Cue-induced craving in patients with cocaine use disorder predicts cognitive control deficits toward cocaine cues. Addict Behav. 2015 Aug; 47:86-90.
    View in: PubMed
    Score: 0.006
  50. Carreiro S, Smelson D, Ranney M, Horvath KJ, Picard RW, Boudreaux ED, Hayes R, Boyer EW. Real-time mobile detection of drug use with wearable biosensors: a pilot study. J Med Toxicol. 2015 Mar; 11(1):73-9.
    View in: PubMed
    Score: 0.006
  51. Rogers E, Fernandez S, Gillespie C, Smelson D, Hagedorn HJ, Elbel B, Kalman D, Axtmayer A, Kurowski K, Sherman SE. Telephone care coordination for smokers in VA mental health clinics: protocol for a hybrid type-2 effectiveness-implementation trial. Addict Sci Clin Pract. 2013 Mar 15; 8:7.
    View in: PubMed
    Score: 0.006
  52. Ellison ML, Mueller L, Smelson D, Corrigan PW, Torres Stone RA, Bokhour BG, Najavits LM, Vessella JM, Drebing C. Supporting the education goals of post-9/11 veterans with self-reported PTSD symptoms: a needs assessment. Psychiatr Rehabil J. 2012; 35(3):209-17.
    View in: PubMed
    Score: 0.005
  53. Valenstein M, Kavanagh J, Lee T, Reilly P, Dalack GW, Grabowski J, Smelson D, Ronis DL, Ganoczy D, Woltmann E, Metreger T, Wolschon P, Jensen A, Poddig B, Blow FC. Using a pharmacy-based intervention to improve antipsychotic adherence among patients with serious mental illness. Schizophr Bull. 2011 Jul; 37(4):727-36.
    View in: PubMed
    Score: 0.004
  54. Banerjea R, Pogach LM, Smelson D, Sambamoorthi U. Mental illness and substance use disorders among women veterans with diabetes. Womens Health Issues. 2009 Nov-Dec; 19(6):446-56.
    View in: PubMed
    Score: 0.004
  55. Banerjea R, Sambamoorthi U, Smelson D, Pogach LM. Expenditures in mental illness and substance use disorders among veteran clinic users with diabetes. J Behav Health Serv Res. 2008 Jul; 35(3):290-303.
    View in: PubMed
    Score: 0.004
  56. Banerjea R, Sambamoorthi U, Smelson D, Pogach LM. Chronic illness with complexities: mental illness and substance use among Veteran clinic users with diabetes. Am J Drug Alcohol Abuse. 2007; 33(6):807-21.
    View in: PubMed
    Score: 0.004
  57. Sussner BD, Smelson DA, Rodrigues S, Kline A, Losonczy M, Ziedonis D. The validity and reliability of a brief measure of cocaine craving. Drug Alcohol Depend. 2006 Jul 27; 83(3):233-7.
    View in: PubMed
    Score: 0.003
  58. Rosenheck R, Perlick D, Bingham S, Liu-Mares W, Collins J, Warren S, Leslie D, Allan E, Campbell EC, Caroff S, Corwin J, Davis L, Douyon R, Dunn L, Evans D, Frecska E, Grabowski J, Graeber D, Herz L, Kwon K, Lawson W, Mena F, Sheikh J, Smelson D, Smith-Gamble V. Effectiveness and cost of olanzapine and haloperidol in the treatment of schizophrenia: a randomized controlled trial. JAMA. 2003 Nov 26; 290(20):2693-702.
    View in: PubMed
    Score: 0.003
  59. Roy M, Smelson DA, Roy A. Abnormal electroretinogram in cocaine-dependent patients. Relationship to craving. Br J Psychiatry. 1996 Apr; 168(4):507-11.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.